290 results
Page 6 of 15
8-K
EX-99.2
4zc7iz9c 5ug9ln7q
14 Jan 15
Regulation FD Disclosure
12:00am
8-K
EX-10.1
1in 1euw6gbjljx8
7 Jan 15
Entry into a Material Definitive Agreement
12:00am
424B3
tn8yq 615bls0u4ci
17 Dec 14
Prospectus supplement
12:00am
8-K
EX-99.1
guxs5g rvqftnbn
11 Dec 14
Regulation FD Disclosure
12:00am
8-K
EX-4.1
06sx sj6g5k
22 Oct 14
Transgenomic Announces $2.375 Million Private Placement Financing
12:00am
8-K
EX-99.1
lw7zz2prt56fib
22 Oct 14
Transgenomic Announces $2.375 Million Private Placement Financing
12:00am
8-K
EX-99.1
233bqjga
2 Jul 14
Selective Monetization of Research Market Assets Reflects Strategic Focus on Higher Growth olecular Diagnostics and Personalized Medicine Sectors
12:00am
8-K
EX-99.1
aga gyht6h4ubnfj9ip
19 Mar 14
Dr. Michael A. Luther Joins Transgenomic’s Board of Directors
12:00am
8-K
EX-99.1
1x21xfc50lfbd bjch0
12 Mar 14
Transgenomic Reports Fourth Quarter and Fiscal Year 2013 Financial Results
12:00am
8-K
EX-10.2
hxyo7hz
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
8-K
EX-99.1
g0dzt2go
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
8-K
EX-99.1
jbxn30hdtff
6 Nov 13
Transgenomic Reports Third Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
pqh7z4ag cq856lb
30 Sep 13
Transgenomic Announces Executive Changes
12:00am
8-K
EX-99.1
wifwnhg t0cj
8 May 13
Transgenomic Reports First Quarter 2013 Financial Results
12:00am
424B3
jbknzr1vzxa534
29 Mar 13
Prospectus supplement
12:00am